The challenge of painful crisis in sickle cell disease

JAMA

Volumn 286, Issue 17, 2001, Pages 2152-2153

  Nagel, R L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; CITIEDIL CITRATE; CITRIC ACID; CYANIC ACID DERIVATIVE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY LM 609; NARCOTIC ANALGESIC AGENT; POLOXAMER; UNCLASSIFIED DRUG; UREA DERIVATIVE;

DRUG INDUCED DISEASE; EDITORIAL; HUMAN; PAIN; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

EID: 0035824170     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.17.2152     Document Type: Editorial

References (21)

1. Clinical aspects of sickle cell anemia in adults and children
2. General pathophysiology of sickle cell anemia
3. Convention and experimental approaches to the management of acute vaso-occlusive pain (painful crises)
4. Sickle cell anemia day hospital: An approach for the management of uncomplicated painful crises
5. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia
6. Sickle cell anemia: A molecular disease
7. Gene mutations in human haemoglobin: The chemical difference between normal and sickle haemoglobin
8. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
9. Fetal hemoglobin in sickle cell anemia: Determinants of response to hydroxyurea
10. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease
11. Bone marrow transplantation in sickle cell anemia
12. Therapeutic haemoglobin synthesis in betathalassaemic mice expressing lentivirus-encoded human β-globin
13. Correction of sickle cell disease in transgenic mouse models by hematopoietic gene therapy
14. Treatment of sickle cell crisis with urea in invert sugar: A controlled trial
15. Toxictherapeutic ratio of sodium cyanate
16. Cyanate-induced cataracts in patients with sickle-cell hemoglobinopathies
17. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease
18. Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial
19. Modeling sickle cell vaso-occlusion in the rat leg: Quantification of trapped sickle cells and correlation with 31 P metabolic and 1 H magnetic resonance imaging changes
20. Ameliorating effects of fluorocarbon on sickle red blood cell-induced obstruction in an ex vivo vasculature
21. Monoclonal antibodies to αVβ3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor